Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongxin Dongtai (Beijing) Biotechnology Co., Ltd. is a life sciences company headquartered in Beijing, China, that specializes in the development and distribution of molecular diagnostic reagents and research tools. Founded in 2012, the company provides a comprehensive portfolio of products including nucleic acid extraction kits, PCR detection reagents, and immunological assay components. Their offerings support a wide range of applications in clinical diagnostics, particularly in the fields of infectious diseases and oncology. In addition to product manufacturing, Zhongxin Dongtai offers technical services such as gene sequencing and customized protein expression to academic and industrial partners. The company is recognized as a high-tech enterprise, contributing to the advancement of precision medicine and laboratory research within the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhong Xin Dong Tai.